Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Lisinopril (ACE Inhibitor)
Treatment for Myocarditis
Typical Dosage: 2.5-40 mg daily
Effectiveness
85%
Safety Score
70%
Clinical Trials
300
Participants
200K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
2.5-40 mg daily
Time to Effect
2-4 weeks for full cardiac remodeling benefits
Treatment Duration
Lifetime
Evidence Quality
HIGHNumber Needed to Treat (NNT)
12(Treat 12 patients to see 1 additional successful outcome)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$100
Monitoring:$600
Side Effect Mgmt:$75
Total Annual:$775
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
1.5
Outcome-Based Costs
Cost per Responder
$1,033
Prescription Access Economics
Annual Societal Loss per Patient
$95
Cost of prescription-only barriers (visits, time, admin, price premium)
Physician Visit Cost
$375/year
Time Cost
$90/year
Travel + wait time
Insurance Admin Cost
$80/year
Prior auth, claims
Rx Price
$100/year
Potential OTC Price
$50/year
Estimated if OTC available
Early Treatment Benefit
+0.10 QALYs
From faster OTC access
Risk Assessment
Misuse Risk
MODERATEMissed Diagnosis Risk
LOWRequires Monitoring
YesNeeds lab work/checkups
Lisinopril (ACE Inhibitor) Outcomes
for Myocarditis
Efficacy Outcomes
Overall Effectiveness
+85%
Response Rate
+75%
Common Side Effects
Cough
+15%
Dizziness/Hypotension
+8%
Hyperkalemia
+7%
Renal dysfunction
+2%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov